Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
about
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusToll-like receptors: key players in antiviral immunityToll-like receptors in antiviral innate immunityThe innate immune system of the perinatal lung and responses to respiratory syncytial virus infectionInduction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine designModulation of host adaptive immunity by hRSV proteinsCritical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesisPhylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in childrenRespiratory viral infections and host responses; insights from genomicsSpace and time: New considerations about the relationship between Toll-like receptors (TLRs) and type I interferons (IFNs)A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eyeA Role for Neutrophils in Viral Respiratory Disease.Respiratory syncytial virus infection induces higher Toll-like receptor-3 expression and TNF-α production than human metapneumovirus infectionEvasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice.Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virusAnti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro.Rhinovirus-induced macrophage cytokine expression does not require endocytosis or replicationAssembly and biological and immunological properties of Newcastle disease virus-like particles.Toll-like receptor 2-mediated innate immune responses against Junín virus in mice lead to antiviral adaptive immune responses during systemic infection and do not affect viral replication in the brainActivation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model.Schistosoma japonicum infection induces macrophage polarization.Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort.Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone.TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infectionInnate immune recognition of respiratory syncytial virus infection.New insights for development of a safe and protective RSV vaccineDecreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infectionQuantitative proteomic analysis of A549 cells infected with human respiratory syncytial virusThe airway epithelium: soldier in the fight against respiratory virusesHIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10.Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses.Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infectionKaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88Novel drugs targeting Toll-like receptors for antiviral therapy.Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies
P2860
Q26748856-E51F2D7E-C5F5-48D4-8649-0E3C3932D858Q26865983-B0B0DED4-DAA2-40D2-9262-4AC66E42A67FQ27011462-3F422F82-6DE3-49CA-9798-59DEBBFFEF14Q27011872-5B1DFDF8-D8AA-4937-BC05-7C4EE587F355Q27021304-BF9D6234-7511-47C6-B29B-974B28358772Q27022693-6BD7369E-DA70-4011-A8B8-338811A3850DQ27302959-2A1203E1-7028-4862-8AA0-893E51B1BAAEQ27329785-80B7371F-33BA-466E-B106-9433D21DDB91Q28079922-6833A44E-B841-41A8-B145-AB8857D2D043Q28081328-99EEC6B6-4119-4E0B-AE37-07B44F9574E3Q28258798-CDB2FD28-AAEF-4EE6-B558-73815355F0FFQ30234336-F3877243-357D-4B91-895A-6C2C057D366AQ31139109-F6B00F1D-0E29-4E04-B3D0-7D93CCC2F745Q33511964-D3455ACA-9F93-470F-AC6C-378DCFA839C5Q33558475-02C3E5F2-0270-413B-98CC-25CE88B214E2Q33591243-70A9E47F-CD8B-4068-8A6B-C9F4E663C36BQ33625617-7C54A820-71BF-4AFA-98F3-E16F49FA72B8Q33658939-324557E4-CFB8-4E4E-9026-D9F7C6728A4AQ33784124-5054CD5A-DD23-482E-A84C-67368F752024Q33799737-DD4B400C-C093-4818-A171-5A07389ED8E6Q33826688-62A1CA98-2778-4642-9803-64FBD38136EEQ33900343-D8DEC2BF-D36D-415D-B816-23AC723C4D00Q33901537-69C3972C-F243-41C1-85E1-4C6054FFFDF9Q33917757-BD0C9DA4-8160-414C-BB72-7BE63398BCEAQ33988118-082456E2-D488-403D-8B68-185CC05709A0Q34059404-05DBEB57-1334-40D0-8F41-8F58D2AB43C6Q34130570-916E5588-089C-4368-B0B9-7FDEF0864C88Q34147516-1932201F-1776-4B9E-8DDA-05CD6C53C547Q34180049-0D46213D-C2C6-4F67-86C3-AF314D9657C4Q34249859-E060F9FF-A6EB-4AC5-B3E9-CE6DF0CDC5ACQ34282702-248FC0EA-D1AF-435F-9BF5-3B9049510578Q34320755-4EF0A0BA-62E0-4698-9C00-2A733D3D8230Q34491598-56125EF0-D950-4F6C-82F2-AC822D9C7BBDQ34508575-FEA86087-500B-416E-9AD5-D3EEDE1B719DQ34674831-215C8CF6-74C8-4705-975C-8EE793C8B113Q34819672-A551B47B-EB9B-4886-8970-506F265145BBQ34943083-BBD26ECF-FAEC-4C12-B750-472ED4A9984AQ34992629-3844B063-C022-463E-A44F-04CE80D518D7Q34999938-8B9217F9-064A-4F0D-A8E6-8A9B608D1F16Q35058641-85875DA4-105F-49B8-8769-703CAD9EB45B
P2860
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
@en
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
@nl
type
label
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
@en
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
@nl
prefLabel
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
@en
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
@nl
P2093
P2860
P356
P1433
P1476
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.
@en
P2093
Anna M Cerny
Evelyn A Kurt-Jones
Glennice N Bowen
Larry J Anderson
Lia M Haynes
Matthew R Murawski
Ralph A Tripp
Robert W Finberg
P2860
P304
P356
10.1128/JVI.00671-08
P407
P577
2008-11-19T00:00:00Z